|
시장보고서
상품코드
2069119
등온 핵산 증폭 기술 시장 규모, 점유율 및 성장 분석 : 기술별, 제품별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Isothermal Nucleic Acid Amplification Technology Market Size, Share, and Growth Analysis, By Technology, By Product, By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 등온 핵산 증폭 기술 시장 규모는 2024년에 47억 달러로 평가되었고, 2025년 50억 4,000만 달러에서 2033년까지 88억 6,000만 달러로 성장하여 예측 기간(2026-2033년)에 CAGR 7.3%를 기록할 전망입니다.
세계 등온 핵산 증폭 기술 시장은 DNA 및 RNA 복제 과정에서 일정한 온도를 유지하는 기법에 초점을 맞추고 있으며, PCR에서 일반적으로 사용되는 서모사이클러가 필요하지 않습니다. 이 기술을 통해 감염병 감시, 식품 안전 및 종양학 분야에서 필수적인 신속하고 휴대 가능한 분자 검사가 가능해집니다. 특히 건강 위기 상황에서 두드러지게 나타난 현장 진단(Point-of-Care)에 대한 수요 급증에 힘입어, 시장은 확장성과 분석 기능을 강화하는 디지털 헬스 플랫폼의 통합과 함께 진화하고 있습니다. 그 결과, 검사 결과를 몇 분 만에 확인할 수 있게 되었으며, 모바일 앱 및 전자 진료 기록과의 연동이 용이해져 효과적인 역학 추적이 가능해졌습니다. 또한, AI를 활용한 자동화를 통해 분석법 설계 및 운영 효율이 향상되고 있으며, 이는 신흥 시장에서의 투자와 도입을 촉진하여 궁극적으로 시장 성장을 가속화하고 의료 솔루션을 더욱 충실하게 만들고 있습니다.
세계 등온 핵산 증폭 기술 시장의 성장 요인
임상 현장과 현장 환경 모두에서 병원체를 신속하게 검출해야 할 필요성이 높아짐에 따라, 등온 핵산 증폭 기술의 도입이 가속화되고 있습니다. 이 기법은 불과 몇 분 만에 결과를 얻을 수 있고, 복잡한 열순환 과정이 필요하지 않기 때문에 현장 진단 검사에 적합합니다. 검사 소요 시간을 대폭 단축함으로써, 적시에 치료 결정을 내릴 수 있게 하여 환자의 예후를 개선하는 동시에 업무 효율을 높입니다. 그 결과, 이러한 속도 면에서의 우위 덕분에 검사실, 병원 및 이동식 검사 유닛이 등온 증폭 기술을 진단 워크플로우에 도입하는 것이 촉진되었으며, 이는 전 세계의 다양한 의료 시스템과 공중보건 정책에 이점을 가져다주고 있습니다.
세계 등온 핵산 증폭 기술 시장의 제약 요인
등온 핵산 증폭 장치, 소모품 및 관련 소프트웨어에 필요한 초기 투자 비용이 높기 때문에 신흥 시장의 소규모 검사실이나 의료 서비스 제공업체들에게는 큰 장벽이 되고 있습니다. 이러한 재정적 장벽으로 인해, 대규모 예산 조정이나 외부 자금 없이는 이 기술을 도입할 수 있는 능력이 제한될 것이며, 비용에 민감한 지역에서는 조기 도입이 저해되어 시장 성장이 둔화될 가능성이 있습니다. 그 결과, 등온 플랫폼이 제공하는 장점에도 불구하고 잠재적 구매자들은 더 저렴한 기존 PCR 방식을 선택할 가능성이 있습니다. 게다가 투자 회수나 지속적인 유지 관리 비용에 대한 우려도 도입에 소극적인 태도로 이어져, 시장 침투 과정을 장기화시키고 있습니다.
세계 등온 핵산 증폭 기술 시장 동향
세계 등온 핵산 증폭 기술 시장에서는 현장 진단(Point-of-Care) 도입을 향한 뚜렷한 추세가 나타나고 있으며, 이는 의료 제공 방식을 근본적으로 변화시키고 있습니다. 이 기술이 본래 지닌 간편성, 신속한 결과, 최소한의 장비 요건 덕분에 의료진은 효율적인 감염병 선별 검사를 위해 휴대용 검사 키트를 사용할 수밖에 없습니다. 그 결과, 중앙 검사실에 대한 의존도가 현저히 낮아져 다양한 의료 현장에서 신속한 의사결정이 가능해졌습니다. 수요의 급증은 생명공학 기업과 현장 진단 기기 제조업체 간의 협력을 촉진하고 있으며, 특히 신흥 시장 등 자원이 제한된 환경에 대응할 수 있는 사용하기 쉬운 배터리 구동형 플랫폼의 혁신으로 이어지고 있습니다. 이를 통해 궁극적으로 전 세계적으로 환자 치료 성과가 향상될 것입니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 등온 핵산 증폭 기술 시장 규모 : 기술별
세계의 등온 핵산 증폭 기술 시장 규모 : 제품별
세계의 등온 핵산 증폭 기술 시장 규모 : 용도별
세계의 등온 핵산 증폭 기술 시장 규모 : 최종사용자별
세계의 등온 핵산 증폭 기술 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.07.01Global Isothermal Nucleic Acid Amplification Technology Market size was valued at USD 4.7 Billion in 2024 and is poised to grow from USD 5.04 Billion in 2025 to USD 8.86 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).
The global market for isothermal nucleic acid amplification technology focuses on consistent-temperature methods for DNA and RNA replication, eliminating the need for thermocyclers typically employed in PCR. This technology enables rapid, portable molecular testing, essential for infectious disease monitoring, food safety, and oncology applications. Driven by a surging demand for point-of-care diagnostics, particularly highlighted during health crises, the market is evolving with the integration of digital health platforms that enhance scalability and analytics. Consequently, tests yield results in minutes, facilitating connections to mobile apps and electronic health records for effective epidemiological tracking. Additionally, AI-driven automation is enhancing assay design and operational efficiency, prompting increased investments and adoption in emerging markets, ultimately propelling market growth and enriching healthcare solutions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Isothermal Nucleic Acid Amplification Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Isothermal Nucleic Acid Amplification Technology Market Segments Analysis
Global isothermal nucleic acid amplification technology market is segmented by technology, product, application, end user and region. Based on technology, the market is segmented into Loop-Mediated Isothermal Amplification (LAMP), Recombinase Polymerase Amplification (RPA), Helicase-Dependent Amplification (HDA), Nucleic Acid Sequence-Based Amplification (NASBA), Strand Displacement Amplification (SDA), Rolling Circle Amplification (RCA) and Other Isothermal Amplification Technologies. Based on product, the market is segmented into Reagents & Kits, Instruments & Analyzers, Consumables and Software & Services. Based on application, the market is segmented into Infectious Disease Testing, Oncology Testing, Genetic & Rare Disease Testing, Blood Screening, Food Safety Testing, Veterinary Diagnostics, Environmental Testing and Other Applications. Based on end user, the market is segmented into Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Point-of-Care Testing Centers, Food & Beverage Testing Laboratories, Veterinary Clinics & Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Isothermal Nucleic Acid Amplification Technology Market
The growing demand for rapid pathogen detection in both clinical and field environments is driving the adoption of isothermal nucleic acid amplification technology. This method provides results in just minutes and eliminates the need for complicated thermal cycling, making it suitable for point-of-care testing. By significantly reducing turnaround times, it facilitates timely therapeutic decisions that enhance patient outcomes and boost operational efficiency. As a result, this speed advantage encourages laboratories, hospitals, and mobile testing units to incorporate isothermal amplification into their diagnostic workflows, thereby benefiting diverse healthcare systems and public health initiatives worldwide.
Restraints in the Global Isothermal Nucleic Acid Amplification Technology Market
The high initial investment required for isothermal nucleic acid amplification instruments, consumables, and associated software creates a significant barrier for small laboratories and healthcare providers in emerging markets. This financial hurdle restricts their capacity to implement the technology without substantial budget adjustments or outside funding, which can hinder early adoption and slow market growth in cost-sensitive areas. As a result, potential buyers may lean towards more affordable traditional PCR methods, despite the advantages offered by isothermal platforms. Furthermore, apprehensions regarding return on investment and ongoing maintenance costs contribute to the reluctance to adopt, lengthening the process for market integration.
Market Trends of the Global Isothermal Nucleic Acid Amplification Technology Market
The Global Isothermal Nucleic Acid Amplification Technology market is witnessing a significant trend towards the adoption of point-of-care diagnostics, fundamentally transforming healthcare delivery. This technology's inherent simplicity, rapid results, and minimal equipment needs are compelling healthcare professionals to utilize portable testing kits for efficient infectious disease screening. As a result, there is a notable decrease in dependence on centralized laboratories, allowing for rapid decision-making in diverse healthcare settings. The surge in demand has spurred collaborations between biotechnology companies and point-of-care device manufacturers, leading to the innovation of user-friendly, battery-operated platforms that cater to low-resource environments, particularly in emerging markets, ultimately enhancing patient care outcomes globally.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Isothermal Nucleic Acid Amplification Technology Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Loop-Mediated Isothermal Amplification (LAMP)
- Recombinase Polymerase Amplification (RPA)
- Helicase-Dependent Amplification (HDA)
- Nucleic Acid Sequence-Based Amplification (NASBA)
- Strand Displacement Amplification (SDA)
- Rolling Circle Amplification (RCA)
- Other Isothermal Amplification Technologies
Global Isothermal Nucleic Acid Amplification Technology Market Size by Product & CAGR (2026-2033)
- Market Overview
- Reagents & Kits
- Instruments & Analyzers
- Consumables
- Software & Services
Global Isothermal Nucleic Acid Amplification Technology Market Size by Application & CAGR (2026-2033)
- Market Overview
- Infectious Disease Testing
- Oncology Testing
- Genetic & Rare Disease Testing
- Blood Screening
- Food Safety Testing
- Veterinary Diagnostics
- Environmental Testing
- Other Applications
Global Isothermal Nucleic Acid Amplification Technology Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Point-of-Care Testing Centers
- Food & Beverage Testing Laboratories
- Veterinary Clinics & Laboratories
- Other End Users
Global Isothermal Nucleic Acid Amplification Technology Market Size & CAGR (2026-2033)
- North America (Technology, Product, Application, End User)
- US
- Canada
- Europe (Technology, Product, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Technology, Product, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Technology, Product, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Technology, Product, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eiken Chemical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Meridian Bioscience, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioMerieux SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TwistDx Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- New England Biolabs, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OptiGene Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HiberGene Diagnostics Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mast Group Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genomtec S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Atila BioSystems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ustar Biotechnologies Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tianlong Science and Technology Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sansure Biotech Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioneer Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fujirebio Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Coris BioConcept
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QuantuMDx Group Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
